[Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)]

[Article in Japanese]

[Article in Japanese]

F Nishioka et al. Rinsho Ketsueki. 1978 Feb.

. 1978 Feb;19(2):100-6.

No abstract available

Similar articles

Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
Garewal H, Durie BG. Garewal H, et al. Ariz Med. 1981 Dec;38(12):912-3. Ariz Med. 1981. PMID: 6174109 No abstract available.
[Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
Balikó Z, Tornóczky J, Pasztarak E, Tóth A, Muth L. Balikó Z, et al. Orv Hetil. 1983 Jan 16;124(3):131-4. Orv Hetil. 1983. PMID: 6188088 Hungarian. No abstract available.
Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
Nakao Y, Matsumoto H, Miyazaki T, Watanabe S, Masaoka T, Takatsuki K, Kishihara M, Kobayashi N, Hattori M, Fujita T. Nakao Y, et al. Clin Exp Immunol. 1981 Oct;46(1):134-41. Clin Exp Immunol. 1981. PMID: 6175458 Free PMC article.
[Beta-2-microglobulin and rheumatic diseases (author's transl)].
Manicourt D. Manicourt D. Acta Rhumatol. 1979 Jan-Mar;3(1):13-28. Acta Rhumatol. 1979. PMID: 92177 Review. French. No abstract available.
Beta-2-microglobulin review: its relevance in clinical oncology.
Cooper EH, Plesner T. Cooper EH, et al. Med Pediatr Oncol. 1980;8(4):323-34. doi: 10.1002/mpo.2950080403. Med Pediatr Oncol. 1980. PMID: 6161299 Review.